Back to search
FDAFDA · Food and drugs·Recall number D-0207-2025

FOUZEE SugarLin HERBAL FORMULA capsules, 180 capsules per bottle, Sold and Distributed by Shoppers-Plaza, Hawthorne, CA 90250. Product of India. UPC 8 26656 69047 7

Published January 29, 2025 · Recall initiated: December 16, 2024

Summary

FDA records drug Class I recall D-0207-2025, published January 29, 2025 and initiated December 16, 2024. Recalling firm: SHOPPERS- PLAZA; Status: Ongoing; Reported quantity: 172 180-count bottles; Lot: Batch # 001, exp. date 09/10/2026. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed product tainted with undeclared metformin and glyburide

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
SHOPPERS- PLAZA
Distributor
Nationwide via internet sales
Lot
Batch # 001, exp. date 09/10/2026
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was FOUZEE SugarLin HERBAL FORMULA capsules, 180 capsules per bottle, Sold and Distributed by Shoppers-Plaza, Hawthorne, CA 90250. Product of India. UPC 8 26656 69047 7 recalled?

Yes. FDA published recall D-0207-2025 on January 29, 2025. Reported hazard: Marketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed product tainted with undeclared metformin and glyburide

What should I do if I have this product?

Voluntary: Firm initiated · Press Release